دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Best Practices for Sharing Images in Clinical Care, Research, and Education—Protecting Patient Privacy
Kanade Shinkai, MD, PhD1,4; Anna L. Bruckner, MD, MSCS2,4; June K. Robinson, MD3
doi : 10.1001/jamadermatol.2023.1080
July 2023, Vol 159, No. 7, Pages 691-793
Biosimilars for the Treatment of Psoriasis—A Systematic Review of Clinical Trials and Observational Studies
Luigi Naldi, MD1,2; Antonio Addis, PharmD3
doi : 10.1001/jamadermatol.2023.1331
July 2023, Vol 159, No. 7, Pages 691-793
Melanoma In Situ—Getting the Diagnosis and Prognosis Right
Anne E. Cust, PhD, MPH(Hons)1,2,3; Richard A. Scolyer, MD, BMedSci, MBBS2,4,5,6
Risk of Mortality After a Diagnosis of Melanoma In Situ
Vishal R. Patel, BS1; Mya L. Roberson, MSPH, PhD2,3; Michael P. Pignone, MD, MPH4; Adewole S. Adamson, MD, MPP3,5,6
Autoimmune, Inflammatory, Atopic, Thyroid, and Psychiatric Outcomes of Offspring Born to Mothers With Alopecia Areata
Ju Yeong Lee, MD1; Hyun Jeong Ju, MD, PhD2; Ju Hee Han, MD, PhD3; Ji Hae Lee, MD, PhD2; Jung Min Bae, MD, PhD2; Won-Soo Lee, MD, PhD1; Solam Lee, MD, PhD1
Risk of Venous Thromboembolism Among Adults With Atopic Dermatitis
Tai-Li Chen, MD1,2; Wan-Ting Huang, MSc3; Ching-Hui Loh, MD, PhD4,5; Huei-Kai Huang, MD5,6,7; Ching-Chi Chi, MD, MMS, DPhil8,9
Validation of the 2022 National Comprehensive Cancer Network Risk Stratification for Cutaneous Squamous Cell Carcinoma
Jacqueline S. Stevens, MD, PhD1; Fadi Murad, MD, MPH1; Timothy D. Smile, MD2; Daniel M. O’Connor, MD1; Evelyn Ilori, MD, PhD2; Shlomo Koyfman, MD2; Allison Vidimos, MD2; Abigail B. Waldman, MD1; Emily S. Ruiz, MD, MPH1
Fertility Trends and Adverse Pregnancy Outcomes in Female Patients With Psoriasis in the UK
Teng-Chou Chen, PhD1; Ireny Y. K. Iskandar, PhD2; Rosa Parisi, PhD3; Matthias Pierce, PhD4; Clare Tower, PhD5; C. Elise Kleyn, MD6; Christopher E. M. Griffiths, MD6; Darren M. Ashcroft, PhD1,7; for the Global Psoriasis Atlas
doi : 10.1001/jamadermatol.2023.1400
Importance Evidence regarding fertility trends and obstetric outcomes among patients with psoriasis is limited by studies of small sample sizes, noninclusion of comparators, and the lack of accurate pregnancy records.
Association of Somatic ATP2A2 Damaging Variants With Grover Disease
Devin Seli1; Katharine T. Ellis, BS1,2; Mohamad Goldust, MD1; Khadim Shah, PhD1,2; Ronghua Hu, MD1; Jing Zhou, MD, PhD1; Jennifer M. McNiff, MD1,3; Keith A. Choate, MD, PhD1,2,3
Venous Thromboembolism in Patients With Bullous Pemphigoid
Maria C. Schneeweiss, MD1,2,3; Joseph F. Merola, MD, MMSc2,3; Richard Wyss, PhD1; Jonathan I. Silverberg, MD, PhD, MPH4; Arash Mostaghimi, MD, MPA, MPH2,3
doi : 10.1001/jamadermatol.2023.1461
Importance Studies have linked bullous pemphigoid (BP) with venous thromboembolism (VTE) across several data sources finding 6-fold to 15-fold increased incidence rates.
The Skin of Color Society’s Meeting the Challenge Summit, 2022
Caryn B. C. Cobb, BA1; Candrice R. Heath, MD2; Angel S. Byrd, MD, PhD3,4; Lynn J. McKinley-Grant, MD, MA3,5; Valerie Callender, MD3,6; Adewole S. Adamson, MD, MPP7; Stafford Brown III, MS8; Seemal R. Desai, MD9,10; Donald A. Glass II, MD, PhD9; Tarannum Jaleel, MD, MHSc5; Ginette A. Okoye, MD3; Susan C. Taylor, MD11,12; Valerie M. Harvey, MD, MPH13,14
doi : 10.1001/jamadermatol.2023.1285
Importance Clinical trials remain the cornerstone for determining the safety and efficacy of an intervention. A diverse participant pool in dermatology clinical trials is critical to ensure that results are generalizable among the patient population who will ultimately depend on the efficacy of the intervention.
Biosimilars for the Treatment of Psoriasis
Duc Binh Phan, MSc1; Sarah Elyoussfi, MBBS1; Michael Stevenson, MSc2; Mark Lunt, PhD3; Richard B. Warren, PhD1; Zenas Z. N. Yiu, MBChB, PhD1
doi : 10.1001/jamadermatol.2023.1338
Importance Biosimilars have the potential to reduce costs for the management of moderate-to-severe psoriasis compared with originators. However, the extrapolation of evidence enables the approval of a biosimilar for use in indications held by the originator without directly being studied in clinical trials. Thus, biosimilars can be approved for psoriasis based on extrapolated evidence from other diseases. The availability of evidence for the effectiveness and safety of biosimilars for the treatment of psoriasis is therefore unclear.
Development of a Skin-Directed Scoring System for Stevens-Johnson Syndrome and Epidermal Necrolysis
Margo Waters, BS1; Allison Dobry, MD2; Stephanie T. Le, MD3; Kanade Shinkai, MD, PhD2; Thomas M. Beachkofsky, MD4; Mark D. P. Davis, MD5; Arturo R. Dominguez, MD6; Daniela Kroshinsky, MD, MPH7; Alina Markova, MD8; Robert G. Micheletti, MD9; Arash Mostaghimi, MD, MPA, MPH10; Helena B. Pasieka, MD, MS11,12; Misha Rosenbach, MD9; Lucia Seminario-Vidal, MD, PhD13; John Trinidad, MD, MPH7; Joerg Albrecht, MD, PhD14; Emily M. Altman, MD15; Ryan Arakaki, MD2; Michael Ardern-Jones, DPhil16; Alina G. Bridges, DO17; Adela R. Cardones, MD, MHSc18; Angad A. Chadha, MD19; Jennifer K. Chen, MD20; Steven T. Chen, MD, MPH, MHPEd7
doi : 10.1001/jamadermatol.2023.1347
Importance Scoring systems for Stevens-Johnson syndrome and epidermal necrolysis (EN) only estimate patient prognosis and are weighted toward comorbidities and systemic features; morphologic terminology for EN lesions is inconsistent.
Outbreak of Cosmetology-Acquired Mycobacterium abscessus Skin Infection
Yuansu Jiang, MM1; Xia Lei, MD2; Weiping Lu, MD1
Eruptive Acral Nevi Secondary to Treatment With Chemotherapy
Catherine J. Stewart, MSc1; C. Nicole Hawkins, MD2
Managing Facial Hyperpigmentation
Roopal V. Kundu, MD1; Oyinade Aderibigbe, MD1; Julia M. Riley, MD1
Ecchymotic Plaques on the Scalp of a Man in His 80s
Sophie Diong, MB BCh BAO (Hons)1; Susan O’Gorman, MB BCh BAO (Hons), MSc1; Lisa Mellerick, MB BCh BAO2
Fever, Pancytopenia, and Tender Erythematous Plaques in a Patient With Multiple Myeloma
Misako Yamaga, MD1; Sho Katayama, MD1; Mitsuhito Ota, MD, PhD1
Patterns of Tumor-Infiltrating Lymphocytes Used to Distinguish Primary Cutaneous Squamous Cell Carcinomas That Metastasize
Sepideh Ashrafzadeh, MD1; Ruth K. Foreman, MD, PhD2; Sara Kalra, MS1; Anna Mandinova, MD, PhD1,3,4; Maryam M. Asgari, MD, MPH1,5
Response of Severe Lupus Miliaris Disseminatus Faciei to Treatment With Ruxolitinib Cream
Natalie C. Gorham, BS1; Jonathan Jacobs, MD2; Sean Z. Wu, MD1
Treatment of Netherton Syndrome With Abrocitinib
Chun-Chan Zheng, MD1; Xiao-Xuan Chen, MD1,2; Rui-Tao Zou, MD1,2; Gui-Yue Cai, MD1,2; Rong-Yi Chen, MD, PhD1
